Zobrazeno 1 - 10
of 1 027
pro vyhledávání: '"Drug-induced hypersensitivity"'
Autor:
Linus C. E. Chan, Rehena Sultana, Karen J. L. Choo, Yi Wei Yeo, Shiu Ming Pang, Haur Yueh Lee
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare severe cutaneous adverse drug reaction associated with multi-organ involvement and long-term sequelae. Human herpesviridae species reactivation has been observed, howeve
Externí odkaz:
https://doaj.org/article/f1d614e99c1c4c2791504a0968763793
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundDrug rash with eosinophilia and systemic symptoms (DRESS) is a life-threatening severe cutaneous adverse reaction.ObjectiveThis study aims to study fatal DRESS cases using FAERS database and systematic review.MethodsData of the FDA Adverse
Externí odkaz:
https://doaj.org/article/f44d43cc7c94458db57345c6bcb73507
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundSulfasalazine (SSZ) is commonly prescribed for the treatment of ulcerative colitis, rheumatoid arthritis, and ankylosing spondylitis. However, it can also trigger a severe drug reaction known as Drug Reaction with Eosinophilia and Systemic
Externí odkaz:
https://doaj.org/article/b23f67eeba144f6fa7832510f8d4b8f6
Publikováno v:
JAAD Case Reports, Vol 50, Iss , Pp 138-140 (2024)
Externí odkaz:
https://doaj.org/article/00211d2071f04979bf191c1d3f93fd13
Autor:
A. S. Fedorov, Yu. O. Savelyeva, Yu. Yu. Grabovetskay, L. A. Rudyuk, E. M. Kuchinskaya, M. M. Kostik
Publikováno v:
Современная ревматология, Vol 18, Iss 2, Pp 81-87 (2024)
Drug-induced hypersensitivity syndrome (DIHS) or drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare, potentially fatal systemic reaction characterized by multiorgan damage involving the liver, hematopoietic system and skin, and h
Externí odkaz:
https://doaj.org/article/36601aff2b684f0aac517e6a70af611c
Autor:
Ryohei Ono, Hiroki Kohno, Sae Kaminota, Kaoruko Aoki, Hirotoshi Kato, Togo Iwahana, Takanori Aihara, Masayuki Ota, Goro Matsumiya, Yoshio Kobayashi
Publikováno v:
ESC Heart Failure, Vol 11, Iss 2, Pp 805-810 (2024)
Abstract Giant cell myocarditis (GCM) is a rare but fatal disease that can lead to cardiac failure. Survival with a cardiac standstill requires mechanical circulatory support or a biventricular assist device (BiVAD) and prolonged survival is extremel
Externí odkaz:
https://doaj.org/article/33ff91c739a045028ce842873e51c37e
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 8, Pp 100935- (2024)
Drug reaction with eosinophilia and systemic symptoms (DRESS), also known as drug-induced hypersensitivity syndrome (DiHS), is a severe type of cutaneous adverse reaction. The gold standard therapy for DRESS involves the discontinuation of the culpri
Externí odkaz:
https://doaj.org/article/68a0eb5952414b058e81bce475c7d8cf
Autor:
Rie Tsuburaya-Suzuki, Sachiko Ohori, Kohei Hamanaka, Atsushi Fujita, Naomichi Matsumoto, Masako Kinoshita
Publikováno v:
Frontiers in Genetics, Vol 15 (2024)
Cardiofaciocutaneous syndrome (CFC) is a rare genetic disorder that presents with cardiac, craniofacial, and cutaneous symptoms, and is often accompanied by neurological abnormalities, including neurodevelopmental disorders and epilepsy. Regarding ep
Externí odkaz:
https://doaj.org/article/7ee32f2855f04425ad05a13adade4356
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Allergic reactions to drugs caused by piperacillin-tazobactam are common in clinical practice. However, we also found a few cases of drug-induced hypersensitivity syndrome (DiHS)/Drug reaction with eosinophilia and systemic symptoms (DRESS) caused by
Externí odkaz:
https://doaj.org/article/d143db6240d34eb49a72775ff4f26aea
Autor:
Hideaki Oiwa, Shozo Yoshida, Hideshi Okada, Masahiro Yasunishi, Ryo Kamidani, Kodai Suzuki, Takahito Miyake, Tomoaki Doi, Takayoshi Shimohata, Shinji Ogura
Publikováno v:
International Journal of Emergency Medicine, Vol 16, Iss 1, Pp 1-6 (2023)
Abstract Background Drug-induced hypersensitivity syndrome (DIHS), including Stevens-Johnson syndrome (SJS), is a severe rash that often develops 2–6 weeks after the intake of the causative drug; however, its diagnosis is sometimes difficult. This
Externí odkaz:
https://doaj.org/article/e072d35b85db47d5aff55a6e6c784c9c